Supplier Type
- Trader
- Reagent
- contract manufacturer
- Manufacturer
- custom synthesis
Supplier Region
- Gujarat(43)
- Mumbai(51)
- Ahmedabad(22)
- Maharashtra(32)
- Hyderabad(23)
- Bangalore(3)
- Delhi(15)
- Haryana(2)
- New Delhi(8)
- Uttar Pradesh(5)
- Pune(5)
- Kolkata(5)
- Punjab(2)
- Andhra Pradesh(3)
- Karnataka(6)
- Vadodara(10)
- Telangana(2)
- Beijing(2)
- Tamil Nadu(3)
- Rajasthan(1)
- Kerela(1)
Purity
- NLT 95%
- Min. 14 %
- Magnesium content Min. 14%
- Heat resistant injection stage
- Greater than 99%
- 99.999% (5N)
- 99.98%
- 99.90%
- 99.55%
- 99.50%
- 99.5% min
- 99.5%
- 99.26%
- 99.17%
- 99.00%
- 99.0% minimum
- 99.0%
- 99% MINIMUM
- 99% Min
- 99% HPLC
- > 99%
- 99%
- >99%
- 99 %
- > 99 %
- 98-99%
- 98+
- 98.70%
- 98.58%
- 98.57%
- 98.42%
- 98.33%
- 98.31%
- 98.00%
- 98% minimum
- 98% Min
- 98%
- >98%
- 98 %
- 97-99%
- 97.00%
- >97%
- 97%
- 96.40%
- 96.00%
- 96%
- 95.00%
- 95%
- 91.21%
- 90%
- 90 % Above
- 75%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100 +/- 5%
- 0.5M
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 100mg
- 250mg
- 500mg
- 1gm
- 25
- 50mg
- 200
- 0MG TO GRAM
- 100
- 1g
- 5g
- 50
- 10g
- 25g
- 50g
- 100g
- 100ml
- 100gm
- 500ml
- 500g
- 1kg
- 1L
- 1000g
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250kgs
- 250250 mg.
-
J acid
87-02-5
-
6,6'-Ureylene-bis(1-naphthol-3-sulfonic acid)
134-47-4
-
1H-Isoindol-1-one, 3-(4-chlorophenyl)-2,3-dihydro-3-hydroxy-
956-92-3
-
(4R,12aS)-N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxaMide
1206102-11-5
-
DesosaMinylazithroMycin
117693-41-1
-
1-Oxo Ibuprofen
65813-55-0
-
16α-Methyl-11-oxo Prednisolone
2036-77-3
-
Tofacitinib Impurity J
-
1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-Methyl-2-nitroethene-1,1-diaMine
1331637-48-9
-
Chlorhexidine EP Impurity J
J acid 87-02-5
J acid 87-02-5
J acid 87-02-5
J acid 87-02-5
J acid 87-02-5
J acid 87-02-5
Chlorthalidone Impurity J 956-92-3
IBUPROFEN IMPURITY J 65813-55-0